# Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

> **NCT00449163** · PHASE2 · TERMINATED · sponsor: **University of Miami** · enrollment: 25 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** Bevacizumab
- **DRUG:** Floxuridine
- **DRUG:** Irinotecan
- **DRUG:** Leucovorin

## Key facts

- **NCT ID:** NCT00449163
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03-01
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Study terminated by University of Miami Institutional Review Board
- **Last updated:** 2017-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449163, "Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00449163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*